# PRDM11

## Overview
PRDM11 is a gene that encodes the PR/SET domain 11 protein, a member of the PRDM family of proteins, which are known for their roles in transcriptional regulation through epigenetic mechanisms. The PR/SET domain 11 protein is characterized by the presence of a PR domain, which is homologous to the SET domain, and multiple C2H2 zinc finger motifs, classifying it as a transcription factor. These structural features enable the protein to bind DNA and potentially recruit histone-modifying enzymes, thereby influencing chromatin structure and gene expression (Hohenauer2012The; Di2021The). Although the protein's intrinsic enzymatic activity has not been confirmed, it is implicated in various cellular processes, including stem cell function and differentiation, and may act as a tumor suppressor in certain contexts (Hohenauer2012The; Di2021The). PRDM11's involvement in cancer biology, particularly in childhood acute lymphoblastic leukemia and diffuse large B-cell lymphoma, highlights its clinical significance and potential as a therapeutic target (Casamassimi2020Multifaceted).

## Structure
PRDM11 is a member of the PRDM protein family, characterized by the presence of a PR domain, which is homologous to the SET domain, and a variable number of C2H2 zinc finger motifs. These structural features are typical of DNA-binding transcription factors, allowing PRDM11 to regulate gene expression by binding to specific DNA sequences (Di2021The). The PR domain is associated with potential methyltransferase activity, although direct enzymatic activity has not been confirmed for PRDM11 (Di2021The).

The zinc finger motifs in PRDM11 contribute to its DNA-binding capabilities, enabling it to function as a transcriptional regulator. These motifs are crucial for the protein's ability to interact with DNA and other proteins, facilitating its role in transcriptional activation or repression depending on the cellular context (Di2021The). There are rare splice variants of PRDM11 that lack zinc fingers, which may affect its DNA-binding properties and functional roles (Di2021The).

PRDM11 is part of an evolutionary recent branch of the methyltransferase superfamily, and its structure reflects the evolutionary acquisition of zinc fingers, which has expanded its regulatory capabilities (Di2021The). The protein may undergo post-translational modifications, such as phosphorylation, which can influence its function and interactions. However, specific details on these modifications for PRDM11 are not provided in the available context.

## Function
PRDM11 is a member of the PRDM family of proteins, which are involved in transcriptional regulation through epigenetic mechanisms. It contains a PR domain related to the SET methyltransferase domain, which is typically associated with histone methyltransferase activity, although PRDM11 itself may not possess intrinsic enzymatic activity. Instead, it likely functions by recruiting histone-modifying enzymes to target promoters, thereby influencing chromatin structure and gene expression (Hohenauer2012The).

PRDM11 is characterized by a unique structural feature, a zinc knuckle, which may influence its specific interactions and functions within the cell, as opposed to the zinc finger domains found in other PRDM family members (Hohenauer2012The). This protein is involved in stem cell function and cell differentiation, playing roles in various developmental processes (Hohenauer2012The). PRDM11's involvement in these processes suggests it plays a role in maintaining cellular identity and function, potentially acting as a tumor suppressor in certain contexts (Di2021The). The activity of PRDM11, like other PRDM proteins, is context-dependent, with its roles in development potentially illuminating its pathological mechanisms (Hohenauer2012The).

## Clinical Significance
PRDM11 has been implicated in various cancers due to its role in regulating oncogenes and tumor suppressor pathways. In childhood acute lymphoblastic leukemia (ALL), mutations in PRDM11, specifically homozygous non-synonymous coding mutations, have been shown to negatively affect its function, contributing to disease progression (Casamassimi2020Multifaceted). In diffuse large B-cell lymphoma (DLBCL), particularly the nongerminal center B-cell-like subtype, PRDM11 deficiency is associated with poorer overall survival, suggesting its role as a tumor suppressor (Casamassimi2020Multifaceted).

In the context of B cell lymphoma, studies using an Eµ-Myc mouse model have demonstrated that PRDM11 deletion accelerates Myc-driven lymphomagenesis, while its overexpression induces apoptosis and delays lymphoma onset, highlighting its anti-tumorigenic effects (Casamassimi2020Multifaceted). PRDM11 also participates in a competitive endogenous RNA (ceRNA) network in lung adenocarcinoma (LUAD), where its involvement is linked to poor prognosis. This network includes a triple ceRNA (miR-21-5p-NKAPP1-PRDM11), indicating a role in gene expression regulation through microRNA sponging (Casamassimi2020Multifaceted). These findings underscore the clinical significance of PRDM11 in cancer biology and its potential as a therapeutic target.


## References


[1. (Hohenauer2012The) Tobias Hohenauer and Adrian W. Moore. The prdm family: expanding roles in stem cells and development. Development, 139(13):2267–2282, July 2012. URL: http://dx.doi.org/10.1242/dev.070110, doi:10.1242/dev.070110. This article has 205 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.070110)

[2. (Di2021The) Federico Di Tullio, Megan Schwarz, Habiba Zorgati, Slim Mzoughi, and Ernesto Guccione. The duality of prdm proteins: epigenetic and structural perspectives. The FEBS Journal, 289(5):1256–1275, May 2021. URL: http://dx.doi.org/10.1111/febs.15844, doi:10.1111/febs.15844. This article has 35 citations.](https://doi.org/10.1111/febs.15844)

[3. (Casamassimi2020Multifaceted) Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, Anna Sorrentino, Donatella Fiore, Maria Chiara Proto, Bruno Moncharmont, Patrizia Gazzerro, Maurizio Bifulco, and Ciro Abbondanza. Multifaceted role of prdm proteins in human cancer. International Journal of Molecular Sciences, 21(7):2648, April 2020. URL: http://dx.doi.org/10.3390/ijms21072648, doi:10.3390/ijms21072648. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21072648)